Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - TOTAL ASSETS
Total Assets REGN - Regeneron Pharmaceuticals, Inc.
33.1 B
LAST VALUE
14.04%
2 YEAR CAGR
23.03%
5 YEAR CAGR
27.34%
10 YEAR CAGR